Walleye Capital
HIMS icon

Walleye Capital’s Hims & Hers Health HIMS Stock Holding History

Walleye Capital’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$863K Sell
24,878
-300,875
-92% -$8.08M ﹤0.01% 2254
2026
Q1 		$6.76M Sell
325,753
-54,011
-14% -$1.28M 0.03% 608
2025
Q4 		$12.3M Buy
379,764
+281,897
+288% +$12.1M 0.04% 513
2025
Q3 		$5.55M Buy
97,867
+94,475
+2,785% +$4.84M 0.02% 868
2025
Q2 		$169K Sell
3,392
-7,370
-68% -$333K ﹤0.01% 3481
2025
Q1 		$318K Sell
10,762
-54,218
-83% -$2.01M ﹤0.01% 2913
2024
Q4 		$1.57M Buy
64,980
+22,257
+52% +$551K ﹤0.01% 2001
2024
Q3 		$787K Sell
42,723
-83,008
-66% -$1.49M ﹤0.01% 2880
2024
Q2 		$2.54M Sell
125,731
-295,721
-70% -$4.92M ﹤0.01% 1879
2024
Q1 		$6.52M Buy
421,452
+384,080
+1,028% +$4.33M 0.01% 1108
2023
Q4 		$333K Buy
+37,372
New +$276K ﹤0.01% 3290
2023
Q2 		– Sell
-352,242
Closed -$3.49M – 4535
2023
Q1 		$3.49M Buy
352,242
+276,783
+367% +$2.43M 0.05% 438
2022
Q4 		$484K Sell
75,459
-41,884
-36% -$238K 0.01% 1478
2022
Q3 		$655K Buy
117,343
+27,445
+31% +$165K 0.01% 1266
2022
Q2 		$407K Buy
89,898
+78,060
+659% +$333K 0.01% 1153
2022
Q1 		$63K Sell
11,838
-4,662
-28% -$23.1K ﹤0.01% 1817
2021
Q4 		$108K Buy
+16,500
New +$119K ﹤0.01% 1659
2020
Q4 		– Sell
-10,647
Closed -$125K – 1004
2020
Q3 		$125K Sell
10,647
-164,063
-94% -$1.75M 0.01% 682
2020
Q2 		$1.78M Buy
174,710
+90,197
+107% +$900K 0.4% 72
2020
Q1 		$845K Buy
+84,513
New +$840K 0.19% 148

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Walleye Capital's HIMS Position: Q2 2026 in Review

Walleye Capital reduced its Hims & Hers Health (HIMS) stake by 92% in Q2 2026, selling an estimated $8.08M and leaving 24,878 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Walleye Capital first reported a position in HIMS in Q1 2020 and has held it in 20 quarters since. The position peaked at $12.3M in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Walleye Capital held 24,878 shares of Hims & Hers Health worth $863K as of Q2 2026.
  • Walleye Capital sold 300,875 Hims & Hers Health shares in Q2 2026, an estimated $8.08M.
  • Hims & Hers Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2254 holding.
  • Walleye Capital first reported a position in Hims & Hers Health in Q1 2020 and has held it in 20 quarters since.
  • Walleye Capital's Hims & Hers Health position peaked at $12.3M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.